Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Patients involved in medical decisions

14.06.2011
The sixth International Conference on Shared Decision Making will take place in Maastricht from Sunday 19 through Wednesday 22 June.

In shared decision making, the health care professional does not decide on his or her own which treatment will be administered, but the professional and the patient decide together.

Trudy van der Weijden, professor of Implementation of Clinical Practice Guidelines at Maastricht University: “We are very pleased to have been able to get the conference on this theme to Maastricht. It is a major international event with almost 300 participants from over 20 countries and from many different fields: physicians, nursing scientists and nurses, health scientists, ethicists, epidemiologists, health psychologists and, for the first time, patient representatives in four different countries will participate. We are very proud of this. They can make an important contribution to the discussion.”

The conference attracts a lot of attention in the international medical world and in the press. And that is necessary, according Van der Weijden: “We must spread the message, because it is a movement that deserves to be in the spotlight. When it is applied well, both doctors and patients will benefit from shared decision making.”

What concrete changes does this bring to doctor-patient consultations? "Doctors and patients both have an active role in shared decision making" van der Weijden explains. "Patients can inform themselves about treatment options, through the help of so-called decision aids for example. Health care professionals should offer the decision aids, explain them in understandable language, and listen carefully to the considerations of the patient. National clinical practice guidelines serve as tools and resources to create more consistency in the treatments prescribed by doctors, but they should not be used dogmatically. Doctors should be able to have a flexible interpretation of the guidelines and tailor it to the patient. Shared decision making can provide a framework for that process."

“Deliberation on whether or not to start a treatment, a screening or diagnostic test is done together in a joint decision making process. In this way the patient can take part in deciding whether he or she wishes to be treated according to the first choice option as described in the guidelines themselves, choose an alternative treatment option, or even choose to do something completely different from what is in the guidelines. This is important especially when it comes to deciding between extending life and quality of life. For example, in the treatment of prostate cancer a high dose of radiotherapy has the greatest chance of prolonging life, but also causes unpleasant side effects such as incontinence and impotence. Radiotherapy with a lower dose will prolong life a little less, but there is a much smaller chance of unpleasant side effects. Faced with these dilemmas, everyone makes different choices depending on their personal situation and values," according to Van der Weijden.

The 2011 International Shared Decision Making Conference will be held from 19 to 22 June at the Crowne Plaza Hotel in Maastricht. For more information visit http://www.isdm2011.org

Note to editors:
For more information about the contents of this press release please contact UM press officer Flore Clerkx, tel +31(0)43 3885230, email flore.clerkx@maastrichtuniversity.nl

The UM Marketing and Communications department can be contacted at +31 (0)43 388 5222, email pers@maastrichtuniversity.nl. For urgent matters outside office hours: +31 (0)6 4602 4992

Flore Clerkx | idw
Further information:
http://www.isdm.org
http://www.unimaas.nl/researchmagazine
http://www.isdm2011.org

Further reports about: Shared Care medical decisions practice guidelines

More articles from Event News:

nachricht Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"
13.04.2018 | Max-Planck-Institut für molekulare Genetik

nachricht Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018
12.04.2018 | Forschungsverbund Berlin e.V.

All articles from Event News >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Molecules Brilliantly Illuminated

Physicists at the Laboratory for Attosecond Physics, which is jointly run by Ludwig-Maximilians-Universität and the Max Planck Institute of Quantum Optics, have developed a high-power laser system that generates ultrashort pulses of light covering a large share of the mid-infrared spectrum. The researchers envisage a wide range of applications for the technology – in the early diagnosis of cancer, for instance.

Molecules are the building blocks of life. Like all other organisms, we are made of them. They control our biorhythm, and they can also reflect our state of...

Im Focus: Spider silk key to new bone-fixing composite

University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.

Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

Im Focus: Gamma-ray flashes from plasma filaments

Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.

The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...

Im Focus: Basel researchers succeed in cultivating cartilage from stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

Structured light and nanomaterials open new ways to tailor light at the nanoscale

23.04.2018 | Physics and Astronomy

On the shape of the 'petal' for the dissipation curve

23.04.2018 | Physics and Astronomy

Clean and Efficient – Fraunhofer ISE Presents Hydrogen Technologies at the HANNOVER MESSE 2018

23.04.2018 | Trade Fair News

VideoLinks
Science & Research
Overview of more VideoLinks >>>